Amgen Inc. (AMGN) Q2 2022 Earnings Results

Amgen Beats on EPS, Stock Down 0.06%

Amgen's earnings report showed a positive surprise in EPS, indicating stronger-than-expected profitability. However, the stock reacted slightly down by 0.06%, which may reflect investor caution or broader market trends. The lack of revenue data and guidance could also contribute to the muted stock reaction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$4.65	N/A	+5.56%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's future. They emphasized their focus on innovation and efficiency.

Management highlighted ongoing commitment to innovation and pipeline development.

They noted the importance of maintaining strong operational efficiency.

Amgen Beats on EPS, Stock Down 0.06%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 0.06%

Key numbers

Management commentary